Clinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease

Activity Overview

The successful management of nontuberculous mycobacteria lung disease (NTM-LD) remains challenging owing to the need for long-term treatment, the ongoing risks of adverse drug reactions, and the potential for nonadherence. These factors underscore the importance of specialty referral and shared decision making in the successful management of NTM-LD, as Dr. Anne O’Donnell and her patient, Brinkley, exemplify.

0.50 CE Credit(s)
Expires: December 25, 2020

Target Audience

The target audience for this activity is US-based pulmonologist and infectious disease specialists.

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Describe the current epidemiologic trends and burden posed by nontuberculous mycobacteria lung disease (NTM-LD) and its treatment
  • Institute best practices for NTM-LD management with available treatment options, including proactive monitoring for adverse events and adherence to existing and new treatments
  • Effectively incorporate shared decision making into management of patients with NTM-LD

Activity Faculty

dr._o'donnell_headshot_small

Anne E. O'Donnell, MD

Professor, Medicine
Nehemiah and Naomi Cohen Chair in Pulmonary Disease Research
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
Georgetown University Hospital
Washington, DC